Costco’s Medicare Advantage pitch at 65 comes with a timing twist, insurers can still screen Medigap after a trial period

A new Costco-backed Medicare Advantage plan starting at age 65 is being positioned as an easy entry point into coverage, with a reported $0 premium and the appeal of a familiar retail brand. But a separate warning highlighted the potential downside of the plan’s exit rules, especially for people considering later coverage through a Medigap policy, which can require health underwriting after certain periods.

Medicare Advantage is an alternative way to receive Medicare benefits through a private insurer. Unlike traditional Medicare, Medigap is a separate Medigap supplemental policy designed to help pay some costs not covered by Medicare. In the post drawing attention to Costco’s offering, the key issue was what happens when a person tries to leave Medicare Advantage and return to traditional coverage plus Medigap.

The reported concern centers on a “12-month trial right” that allows some Medicare Advantage enrollees to switch plans during an initial window. According to the warning, once that trial period ends, a Medigap insurer could ask health questions and, in some cases, decline the application. That means the timing of any decision to exit Medicare Advantage may matter as much as the coverage itself.

The article framing the story also emphasizes that at enrollment age 65, the combination of a $0 premium and the convenience of buying into a well-known retail ecosystem can make the plan feel like a low-friction choice. However, the caveat described is that an enrollment decision is not just a one-time decision. It sets up a sequence of options, and the “clock” starts quickly.

Costco’s involvement matters for consumer behavior because the company’s membership model and warehouse brand have historically driven trust and repeat purchase habits. Still, Medicare Advantage is regulated differently than retail offerings, and plan rules are governed by federal Medicare regulations and insurer-specific plan design. In other words, the Costco label does not remove the need to understand how Medicare Advantage trial rights, switching windows, and downstream Medigap eligibility work.

As of the date of the cited report, Costco did not provide additional publicly detailed disclosures in the post itself about enrollment counseling, individualized health screening practices for Medigap, or any insurer-specific exceptions. The warning remains focused on the general mechanism that, after a trial right ends, Medigap underwriting may resume for some applicants.

One uncertainty is the specific plan mechanics the report attributes to Costco’s new Medicare Advantage offering, because the post excerpt available here does not include the plan name, county availability, or whether the insurer offers any special enrollment relief beyond standard Medicare rules. Another open question is how each person’s medical history would be treated under the relevant Medigap application process, since underwriting outcomes can vary by insurer and by timing.

What to watch next is how regulators and plan administrators describe the exit process for Costco’s Medicare Advantage plan, including any clear, plain-language guidance about when consumers should act if they expect to return to traditional Medicare plus Medigap. People evaluating the plan may also want to confirm the status of their Medigap eligibility well before the trial period ends, rather than assuming switching will be frictionless later.